Search results
Results from the WOW.Com Content Network
It is presently classed in schedule I(C) along with its active constituents, the tetrahydrocannibinols and other psychotropic drugs. Some question has been raised whether the use of the plant itself produces "severe psychological or physical dependence" as required by a schedule I or even schedule II criterion. Since there is still a considerable void in our knowledge of the plant and the ...
The Marijuana Opportunity Reinvestment and Expungement Act, also known as the MORE Act, is a proposed piece of U.S. federal legislation that would deschedule cannabis from the Controlled Substances Act and enact various criminal and social justice reforms related to cannabis, including the expungement of prior convictions.
In 2017, a $59 million two-year contract was awarded by the State of California to Florida-based Franwell to create the system and supply RFID tags. [1] The system was first developed for Colorado in 2011. [2] As of mid-2017, Franwell's system was in use in California, Colorado, Oregon, Maryland, Alaska, and Michigan. [3]
The Cole Memorandum was sent to all United States Attorneys and was formally titled "Guidance Regarding Marijuana Enforcement". The Cole Memorandum was a United States Department of Justice memorandum issued August 29, 2013, by United States Deputy Attorney General James M. Cole during the presidency of Barack Obama.
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
A 2013 study showed that 32.8% of people surveyed in Utah, a state where Marijuana use is illegal, believed that they had a risk of harm from Marijuana consumption, whereas only 18.8% of people surveyed in Washington, a state where adult-use is legal, believed they had a risk of harm. [13]
For the treatment of the withdrawal/negative affect symptom domain of cannabis use disorder, medications may work by alleviating restlessness, irritable or depressed mood, anxiety, and insomnia. [58] Bupropion, which is a norepinephrine–dopamine reuptake inhibitor, has been studied for the treatment of withdrawal with largely poor results. [58]
SYSTEM REQUIREMENTS. Mobile and desktop browsers: Works best with the latest version of Chrome, Edge, FireFox and Safari. Windows: Windows 7 and newer Mac: MacOS X and newer Note: Ad-Free AOL Mail ...